<\/p>\n
Encorate Chrono<\/strong> er en 200 \/ 300 \/ 400 \/ 500 \/ 600 mg natriumvalproat \/ valproinsyre forsinket frigj\u00f8ring (chrono \/ CR) tablett<\/strong> fra Sun Pharma \u2014 et antiepileptikum \/ hum\u00f8rstabilisator \/ migr\u00e4nepreventiv. I migr\u00e4neprevensjon brukes det ved 500-1 500 mg en gang daglig<\/strong> som et tredje- eller fjerdevalg etter propranolol, topiramat og amitriptylin. Absolutt kontraindikasjon under graviditet og hos kvinner i fruktbar alder uten graviditetsforebyggende program<\/strong> \u2014 valproat for\u00e5rsaker en 10 % risiko for alvorlige medf\u00f8dte misdannelser (nevralr\u00f8rsdefekter, kraniofacial, hjerte, lemmer, urogenital) og en 30-40 % risiko for nevro-utviklingsmessige vansker (redusert IQ 7-10 poeng, autisme-spektrum). EMA og MHRA har utstedt gradvis strengere forskrivningsrestriksjoner siden 2014. Andre viktige bivirkninger: leverskade (idiosynkratisk; alvorlig sjelden d\u00f8delig), bukspyttkjertelbetennelse, trombocytopeni, hyperammonemi, vekt\u00f8kning, h\u00e5rtap, tremor og polycystisk ovariesyndrom hos kvinner.<\/p>\n<\/div>\n Encorate Chrono er en oral forsinket frigj\u00f8ring (chrono \/ CR) tablett av natriumvalproat \/ valproinsyre 200 \/ 300 \/ 400 \/ 500 \/ 600 mg<\/strong> fra Sun Pharma, levert i 30-180 tablettpakker. Valproat er en forgrenet kortkjedet fettsyre som opprinnelig ble brukt som l\u00f8semiddel i farmas\u00f8ytisk kjemi, senere tilfeldig oppdaget \u00e5 ha antiepileptisk aktivitet. Det har v\u00e6rt et f\u00f8rstelinjes antiepileptikum for generalisert og partiell epilepsi siden 1970-tallet og ble det tredje legemiddelet med godkjenning fra US FDA for migr\u00e4neprofylakse i 1996 (etter propranolol og timolol).<\/p>\n Det Chrono \/ CR forsinket frigj\u00f8ringsformulering<\/strong> tillater en gang daglig dosering med jevnere plasmaniv\u00e5er enn umiddelbar frigj\u00f8ringsformulering \u2014 bedre tolerabilitet (mindre topprelatert kvalme og tremor) og bedre medf\u00f8lgelighet.<\/p>\n Valproat virker gjennom flere mekanismer som er relevante for migrene:<\/p>\n I migreneforebyggende fors\u00f8k (Jensen 1994, Mathew 1995, Klapper 1997) reduserte valproat 500-1,500 mg\/dag m\u00e5nedlig migrenefrekvens med ~50% hos omtrent halvparten av de behandlede pasientene.<\/p>\n Valproat titreres oppover<\/strong> over 2-4 uker for \u00e5 minimere kvalme:<\/p>\n Overv\u00e5kning:<\/strong><\/p>\n Avslutning:<\/strong> trapp ned over 2-4 uker ved opph\u00f8r. Hos pasienter med samtidig epilepsi, aldri avslutt valproat uten nevrologisk vurdering (anfallsrisiko).<\/p>\n Sv\u00e6rt vanlig (>10%):<\/strong> kvalme, dyspepsi, d\u00f8sighet, tremor, vekt\u00f8kning, h\u00e5ravfall, alopecia (vanligvis midlertidig; h\u00e5ret vokser tilbake etter dosereduksjon eller stopp).<\/p>\n Vanlige (1-10%):<\/strong> ataksi, svimmelhet, hodepine, midlertidig forh\u00f8yede leverenzymverdier, trombocytopeni (vanligvis mild og doseavhengig), amenor\u00e9 eller uregelmessig menstruasjon, polycystisk ovariesyndrom (hos yngre kvinner), redusert libido, perifert \u00f8dem.<\/p>\n Sjeldent, men alvorlig:<\/strong><\/p>\n Amming:<\/strong> valproate passes into milk in low amounts (milk\/plasma ratio ~0.02). Generally considered acceptable during breastfeeding if the drug is needed; monitor the infant for unusual lethargy or poor feeding.<\/p>\n Store below 25°C in original blister. Protect from moisture. Keep out of reach of children.<\/p>\n Allow 8-12 weeks at target dose for full effect. Keep a migraine diary recording days per month at baseline and at week 12. A clinically meaningful response is a 50% reduction in monthly migraine days.<\/p>\n Nei.<\/strong> Valproate is one of the most teratogenic drugs in clinical use (~10% malformation risk, 30-40% neurodevelopmental impairment risk). Women of childbearing potential should be switched to a safer preventive (propranolol<\/a> is preferred in pregnancy) before conception. A 3-month washout is usually recommended before trying to conceive. Valproate should not be used in women planning or able to become pregnant without a formal pregnancy-prevention programme.<\/p>\n Same molecule (sodium valproate \/ valproic acid), different release profile. Encorate Chrono is extended-release for once-daily dosing with smoother plasma levels. Better tolerability, better adherence. Encorate IR<\/a> requires twice-daily dosing.<\/p>\n Yes — weight gain is one of the most common side effects (average 3-5 kg over 6-12 months, more in some). Mechanism includes increased appetite, possibly altered glucose metabolism. If weight gain is problematic, consider switching to topiramate<\/a> (which causes weight loss) or propranolol<\/a> (weight-neutral).<\/p>\n Valproate can cause hepatotoxicity, pancreatitis, thrombocytopenia, and hyperammonaemia. Baseline + periodic LFTs, full blood count, and clinical monitoring catch problems early. Therapeutic drug monitoring (levels 50-100 μg\/mL) is not routinely needed for migraine prevention — dose by clinical response.<\/p>\n Avoid regular or heavy alcohol use. Alcohol is additive with valproate’s sedation and adds to hepatic stress. Occasional small amounts are not absolutely contraindicated but regular drinking raises the risk of hepatotoxicity. Alcohol is also a common migraine trigger; reducing intake often improves migraine independent of valproate.<\/p>\n No — taper over 2-4 weeks. Abrupt discontinuation can trigger rebound migraine and, in patients with any seizure tendency, seizure.<\/p>\n You can buy Encorate Chrono (sodium valproate 200 \/ 300 \/ 400 \/ 500 \/ 600 mg extended-release (chrono \/ CR) tablet, 30-180 tablet packs) from MedsBase with discreet packaging and worldwide shipping.<\/p>\n \ud83d\udce6 Hver ordre er dekket av v\u00e5r Reshipment Assurance Policy<\/strong><\/a> \u2014 hvis pakken din ikke ankommer innen 20 virkedager, sender vi ny.<\/p>\n <\/p>\n Andre produkter innen Kroniske tilstander<\/strong> som kunder ogs\u00e5 ser p\u00e5:<\/p>\n Encorate Chrono er natriumvalproat 200 \/ 300 \/ 400 \/ 500 \/ 600 mg forsinket frigj\u00f8ring (chrono \/ CR) tabletter fra Sun Pharma \u2014 en gang daglig dosering med jevnere plasmaniv\u00e5er enn umiddelbar frigj\u00f8ring Encorate. For migr\u00e4neprevensjon: start med 500 mg om natten, titrer opp til 1 000 mg om natten (omr\u00e5de 500-1 500 mg). Samme graviditets- og overv\u00e5kingsrestriksjoner som alle valproatprodukter.<\/p>","protected":false},"featured_media":61071,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3553,3141,3223,3342,3554],"product_tag":[4973,4677,4898],"class_list":{"0":"post-61070","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-anti-migraine","7":"product_cat-category-overview","8":"product_cat-chronic-conditions","9":"product_cat-general-health","10":"product_cat-migraine-treatment","11":"product_tag-encorate-chrono","12":"product_tag-sodium-valproate","13":"product_tag-valproic-acid","15":"first","16":"instock","17":"shipping-taxable","18":"purchasable","19":"product-type-variable","20":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/product\/61070","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/comments?post=61070"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/media\/61071"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/media?parent=61070"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/product_brand?post=61070"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/product_cat?post=61070"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/product_tag?post=61070"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Hva er Encorate Chrono?<\/h2>\n
Hvordan valproat forebygger migrene<\/h2>\n
\n
Godkjente Bruksomr\u00e5der<\/h2>\n
\n
Encorate Chrono-dosering for migr\u00e4neprevensjon<\/h2>\n
\n
\n
Bivirkninger<\/h2>\n
\n
Kontraindikasjoner<\/h2>\n
\n
Legemiddelinteraksjoner<\/h2>\n
\n
Oppbevaring<\/h2>\n
Vanlige sp\u00f8rsm\u00e5l<\/h2>\n
How long until Encorate Chrono starts preventing migraines?<\/h3>\n
Is Encorate Chrono safe if I am planning pregnancy?<\/h3>\n
Why is the extended-release form different from Encorate IR?<\/h3>\n
Will Encorate Chrono make me gain weight?<\/h3>\n
Why do I need blood tests on Encorate Chrono?<\/h3>\n
Can I drink alcohol on Encorate Chrono?<\/h3>\n
Can I stop Encorate Chrono abruptly?<\/h3>\n
Where can I buy Encorate Chrono online?<\/h3>\n
Relaterte migrenebehandlinger p\u00e5 MedsBase<\/h2>\n
\n
Hvorfor bestille fra MedsBase<\/h3>\n
Relaterte alternativer<\/h3>\n
\n